CLYDESDALE RESOURCES INC (CEO-H.CA) Fundamental Analysis & Valuation

TSX-V:CEO-H • CA18972D1078

Current stock price

0.145 CAD
+0.01 (+11.54%)
Last:

This CEO-H.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CEO-H.CA Profitability Analysis

1.1 Basic Checks

  • CEO-H had negative earnings in the past year.
  • CEO-H had a negative operating cash flow in the past year.
CEO-H.CA Yearly Net Income VS EBIT VS OCF VS FCFCEO-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 -10K -20K -30K -40K -50K

1.2 Ratios

  • CEO-H has a Return On Assets (-21.26%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.26%
ROE N/A
ROIC N/A
ROA(3y)-17.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CEO-H.CA Yearly ROA, ROE, ROICCEO-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 20 40

1.3 Margins

  • CEO-H does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CEO-H.CA Yearly Profit, Operating, Gross MarginsCEO-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CEO-H.CA Health Analysis

2.1 Basic Checks

  • CEO-H has about the same amout of shares outstanding than it did 1 year ago.
  • CEO-H has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CEO-H.CA Yearly Shares OutstandingCEO-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M
CEO-H.CA Yearly Total Debt VS Total AssetsCEO-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 50K 100K 150K 200K 250K

2.2 Solvency

  • CEO-H has an Altman-Z score of -13.49. This is a bad value and indicates that CEO-H is not financially healthy and even has some risk of bankruptcy.
  • CEO-H's Altman-Z score of -13.49 is on the low side compared to the rest of the industry. CEO-H is outperformed by 73.72% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.49
ROIC/WACCN/A
WACCN/A
CEO-H.CA Yearly LT Debt VS Equity VS FCFCEO-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 -50K -100K -150K -200K

2.3 Liquidity

  • CEO-H has a Current Ratio of 0.50. This is a bad value and indicates that CEO-H is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CEO-H has a worse Current ratio (0.50) than 71.34% of its industry peers.
  • A Quick Ratio of 0.50 indicates that CEO-H may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.50, CEO-H is not doing good in the industry: 70.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.5
CEO-H.CA Yearly Current Assets VS Current LiabilitesCEO-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 100K 200K 300K 400K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CEO-H.CA Growth Analysis

3.1 Past

  • CEO-H shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.33%.
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CEO-H.CA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CEO-H.CA Price Earnings VS Forward Price EarningsCEO-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEO-H.CA Per share dataCEO-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0 -0 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CEO-H.CA Dividend Analysis

5.1 Amount

  • No dividends for CEO-H!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CEO-H.CA Fundamentals: All Metrics, Ratios and Statistics

CLYDESDALE RESOURCES INC

TSX-V:CEO-H (4/7/2026, 7:00:00 PM)

0.145

+0.01 (+11.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.60M
Revenue(TTM)N/A
Net Income(TTM)-56.40K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.5
Altman-Z -13.49
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0%
OCF growth 3YN/A
OCF growth 5YN/A

CLYDESDALE RESOURCES INC / CEO-H.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CLYDESDALE RESOURCES INC (CEO-H.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to CEO-H.CA.


What is the valuation status for CEO-H stock?

ChartMill assigns a valuation rating of 0 / 10 to CLYDESDALE RESOURCES INC (CEO-H.CA). This can be considered as Overvalued.


How profitable is CLYDESDALE RESOURCES INC (CEO-H.CA) stock?

CLYDESDALE RESOURCES INC (CEO-H.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for CEO-H stock?

The financial health rating of CLYDESDALE RESOURCES INC (CEO-H.CA) is 1 / 10.